Consejo Nacional de Salud

14 Kontoghiorghes GJ., Transparency and access
to full information for the fatal or serious toxicity
risks, low efficacy and high price of deferasirox,
could increase the prospect of improved
iron chelation therapy worldwide. Hemoglobin.
2008;32(6):608-15. No abstract available.
PMID: 19065341 [PubMed - in process]
15 Porter JB, Taher AT, Cappellini MD, Vichinsky
EP Ethical issues and risk/benefit assessment
of iron chelation therapy: advances with
deferiprone/deferoxamine combinations and
concerns about the safety, efficacy and costs of
deferasirox [Kontoghiorghes GJ, Hemoglobin
2008; 32(1-2):1-15.]. .
Hemoglobin. 2008;32(6):601-7; author reply
608-15. No abstract available
16 Kongnyuy EJ, Wiysonge CS. Interventions to
reduce haemorrhage during myomectomy
for fibroids. Cochrane Database of Systematic
Reviews 2007, Issue 1. Art. No.: CD005355.
DOI: 10.1002/14651858.CD005355.pub2.
17 Shelley M, Harrison C, Coles B, Stafforth J,
Wilt T, Mason M. Chemotherapy for hormonerefractory
prostate cancer. Cochrane Database
of Systematic Reviews 2006, Issue 4. Art.
No.: CD005247. DOI: 10.1002/14651858.
CD005247.pub2
18 van Dalen EC, Caron HN, Dickinson HO,
Kremer LCM. Cardioprotective interventions
for cancer patients receiving anthracyclines.
Cochrane Database of Systematic Reviews
2008, Issue 2. Art. No.: CD003917. DOI:
10.1002/14651858.CD003917.pub3
19 [Xu WQ, Tang YM, Fang CQ, Song H, Shi SW,
Yang SL, Ren DT, Shen HQ, Qian BQ Study on
elimination delay in high dose methotrexate
therapy in childhood acute lymphoblastic leukemia.
Zhonghua Xue Ye Xue Za Zhi. 2005
Jan;26(1):15-8. Chinese. PMID: 15946502
[PubMed - in process]
20 Fang Y, Wang YJ, Li F, Li J.Oxaliplatin in combination
with calcium folinate and fluorouracil as
neoadjuvant chemotherapy in the treatment of
advanced gastric cancer, Zhonghua Wei Chang
Wai Ke Za Zhi. 2006 Nov;9(6):510-2. Chinese.
PMID: 17143797 [PubMed - in process]
21 Albers J, Chaudhry V, Cavaletti G, Donehower
R. Interventions for preventing neuropathy
caused by cisplatin and related compounds.
Cochrane Database of Systematic Reviews
2007, Issue 1. Art. No.: CD005228. DOI:
10.1002/14651858.CD005228.pub2
22 Koukourakis MI, Tsoutsou PG, Abatzoglou IM,
Sismanidou K, Giatromanolaki A, Sivridis E Hypofractionated
and Accelerated Radiotherapy
with Subcutaneous Amifostine Cytoprotection
as Short Adjuvant Regimen After Breast-Conserving
Surgery: Interim Report., Int J Radiat
Oncol Biol Phys. 2008 Dec 4. [Epub ahead of
print] PMID: 19058920 [PubMed - as supplied
by publisher]
23 Dinçba_ FO, Oksüz DC, Atalar B, Altug T, Ilvan
S, Gedik N, Ozel S, Koca S., The role of amifostine
on late normal tissue damage induced by
pelvic radiotherapy with concomitant gemcitabine:
an in vivo study. Med Oncol. 2008 Nov
30. [Epub ahead of print] PMID: 19043677
[PubMed - as supplied by publisher]
GRUPO V | Variados
565
V